Venbio Select Advisor Trimmed Its Immunomedics (Call) (IMMU) Holding by $67.29 Million; As Microsoft (MSFT) Market Valuation Rose, Shareholder Bill & Melinda Gates Foundation Trust Has Cut Holding

February 15, 2018 - By Louis Casey

Venbio Select Advisor Llc decreased its stake in Immunomedics Inc (Call) (IMMU) by 91.66% based on its latest 2017Q3 regulatory filing with the SEC. Venbio Select Advisor Llc sold 9.61 million shares as the company’s stock rose 37.64% with the market. The institutional investor held 875,000 shares of the health care company at the end of 2017Q3, valued at $6.30 million, down from 10.49M at the end of the previous reported quarter. Venbio Select Advisor Llc who had been investing in Immunomedics Inc (Call) for a number of months, seems to be less bullish one the $2.70 billion market cap company. The stock increased 1.62% or $0.26 during the last trading session, reaching $16.26. About 967,120 shares traded. Immunomedics, Inc. (NASDAQ:IMMU) has risen 76.26% since February 15, 2017 and is uptrending. It has outperformed by 59.56% the S&P500.

Michael Larson decreased its stake in Microsoft Corp (MSFT) by 12.5% based on its latest 2017Q3 regulatory filing with the SEC. Bill & Melinda Gates Foundation Trust sold 8.00 million shares as the company’s stock rose 4.75% with the market. The hedge fund run by Michael Larson held 56.00 million shares of the prepackaged software company at the end of 2017Q3, valued at $4.17B, down from 64.00M at the end of the previous reported quarter. Bill & Melinda Gates Foundation Trust who had been investing in Microsoft Corp for a number of months, seems to be less bullish one the $710.85 billion market cap company. The stock increased 1.66% or $1.51 during the last trading session, reaching $92.32. About 15.36 million shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 34.52% since February 15, 2017 and is uptrending. It has outperformed by 17.82% the S&P500.

Since August 21, 2017, it had 0 insider purchases, and 6 sales for $2.10 million activity. 20,000 shares were sold by GOLDENBERG CYNTHIA L, worth $252,750 on Thursday, August 31.

Among 3 analysts covering Immunomedics (NASDAQ:IMMU), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Immunomedics had 15 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was downgraded by Jefferies on Wednesday, July 29 to “Hold”. The firm has “Buy” rating given on Monday, October 9 by Jefferies. The firm has “Buy” rating given on Monday, July 24 by Cowen & Co. Jefferies reinitiated the shares of IMMU in report on Thursday, October 6 with “Buy” rating. The rating was maintained by Jefferies on Tuesday, September 19 with “Buy”. As per Tuesday, June 21, the company rating was downgraded by Wells Fargo. The firm has “Buy” rating given on Friday, June 9 by Jefferies. Jefferies upgraded the stock to “Buy” rating in Friday, May 6 report. The firm has “Market Perform” rating by Wells Fargo given on Friday, December 4. On Wednesday, December 6 the stock rating was maintained by Jefferies with “Buy”.

Venbio Select Advisor Llc, which manages about $380.08M and $1.29 billion US Long portfolio, upped its stake in Viveve Medical Inc by 237,776 shares to 1.03M shares, valued at $5.41M in 2017Q3, according to the filing. It also increased its holding in Teligent Inc by 447,430 shares in the quarter, for a total of 4.58 million shares, and has risen its stake in Array Biopharma Inc (NASDAQ:ARRY).

Investors sentiment increased to 1.65 in Q3 2017. Its up 0.24, from 1.41 in 2017Q2. It is positive, as 16 investors sold IMMU shares while 36 reduced holdings. 38 funds opened positions while 48 raised stakes. 111.69 million shares or 33.14% more from 83.89 million shares in 2017Q2 were reported. Ifc Holding Fl owns 40,150 shares. State Bank Of Ny Mellon Corporation invested in 681,419 shares. American Interest Grp holds 0% or 68,533 shares in its portfolio. Moreover, Fny Managed Accounts Limited Company has 0.01% invested in Immunomedics, Inc. (NASDAQ:IMMU) for 400 shares. Tiaa Cref Investment Mngmt Ltd Liability Corporation owns 272,375 shares for 0% of their portfolio. 304,184 are owned by Voloridge Inv Management Ltd Limited Liability Company. Schwab Charles Management Inc holds 468,380 shares or 0.01% of its portfolio. Suntrust Banks owns 28,400 shares or 0% of their US portfolio. Sphera Funds Mngmt Ltd invested 0.9% in Immunomedics, Inc. (NASDAQ:IMMU). Dafna Capital Mgmt Ltd Com reported 4% in Immunomedics, Inc. (NASDAQ:IMMU). Iguana Healthcare Mgmt Lc holds 3.9% or 500,000 shares in its portfolio. Chicago Equity Partners Ltd Liability Company owns 323,320 shares. Quantitative Ltd Llc holds 0% in Immunomedics, Inc. (NASDAQ:IMMU) or 25,200 shares. Jennison Limited Liability has invested 0.03% of its portfolio in Immunomedics, Inc. (NASDAQ:IMMU). 683 Capital Mngmt Ltd Co reported 225,000 shares.

Among 37 analysts covering Microsoft Corporation (NASDAQ:MSFT), 29 have Buy rating, 2 Sell and 6 Hold. Therefore 78% are positive. Microsoft Corporation had 166 analyst reports since July 22, 2015 according to SRatingsIntel. Cowen & Co maintained Microsoft Corporation (NASDAQ:MSFT) on Tuesday, October 31 with “Buy” rating. The firm has “Buy” rating by Stifel Nicolaus given on Friday, July 21. The firm has “Buy” rating by Stifel Nicolaus given on Friday, October 27. The rating was reinitiated by Oppenheimer with “Outperform” on Thursday, March 17. The firm earned “Buy” rating on Friday, August 7 by Oppenheimer. KeyBanc Capital Markets maintained Microsoft Corporation (NASDAQ:MSFT) rating on Monday, September 25. KeyBanc Capital Markets has “Buy” rating and $82.0 target. The rating was maintained by FBR Capital with “Outperform” on Friday, October 23. The stock has “Buy” rating by Barclays Capital on Friday, October 27. Canaccord Genuity maintained Microsoft Corporation (NASDAQ:MSFT) on Thursday, July 6 with “Hold” rating. Jefferies maintained Microsoft Corporation (NASDAQ:MSFT) on Thursday, October 26 with “Sell” rating.

Investors sentiment increased to 0.83 in Q3 2017. Its up 0.01, from 0.82 in 2017Q2. It improved, as 40 investors sold MSFT shares while 952 reduced holdings. 114 funds opened positions while 708 raised stakes. 5.51 billion shares or 0.32% less from 5.53 billion shares in 2017Q2 were reported. Evanson Asset Limited Liability Corp has invested 0.33% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Banced holds 0.85% of its portfolio in Microsoft Corporation (NASDAQ:MSFT) for 6,572 shares. Essex Investment Management Limited Liability Corporation holds 1.12% or 110,393 shares. 113.07M are held by Natl Bank Of New York Mellon. Motco, Texas-based fund reported 75,297 shares. Morgan Dempsey Mgmt Limited Liability Co holds 0.03% of its portfolio in Microsoft Corporation (NASDAQ:MSFT) for 1,045 shares. Advisor Ptnrs Limited reported 2.32% in Microsoft Corporation (NASDAQ:MSFT). Shayne And Com Ltd Liability Corp stated it has 19,795 shares or 1.11% of all its holdings. Ulysses Mgmt Limited Liability invested in 2.09% or 257,500 shares. Veritable LP invested in 0.6% or 381,612 shares. Thomaspartners has invested 2.6% in Microsoft Corporation (NASDAQ:MSFT). Noesis Capital Mangement holds 0.39% of its portfolio in Microsoft Corporation (NASDAQ:MSFT) for 13,814 shares. Fcg Ltd Liability holds 0.53% in Microsoft Corporation (NASDAQ:MSFT) or 20,434 shares. D L Carlson Gp, New Hampshire-based fund reported 130,931 shares. Atlantic Tru Llc owns 6.57 million shares or 2.19% of their US portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts